Limitations of the Laboratory Monitoring of Heparin Therapy
- 1 January 2002
- journal article
- schattauer gmbh
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 87 (01) , 163-164
- https://doi.org/10.1055/s-0037-1612960
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Three different chromogenic methods do not give equivalent anti-Xa levels for patients on therapeutic low molecular weight heparin (dalteparin) or unfractionated heparinClinical and Laboratory Haematology, 1999
- Low-molecular-weight heparins: pharmacologic profile and product differentiationThe American Journal of Cardiology, 1998
- The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparinBlood Coagulation & Fibrinolysis, 1995
- Establishing a Therapeutic Range for Heparin TherapyAnnals of Internal Medicine, 1993
- Factor Xa Inhibition: Correlation between the Plasma Levels of Anti-Xa Activity and Occurrence of Thrombosis and HaemorrhagePathophysiology of Haemostasis and Thrombosis, 1993